Weight loss improved glucose control but briefly intensified hypothalamic inflammation in mid-aged mice, study finds

Weight loss reversed obesity-related glucose problems in both young and mid-aged mice, but researchers at Ben-Gurion University of the Negev report that, in mid-aged animals, early weight loss coincided with a temporary rise in inflammation-related changes in the hypothalamus, a brain region involved in appetite and energy regulation.

Obesity is widely recognized as a major health problem, and weight loss is often recommended to reduce metabolic risks. But new research in mice suggests the brain may respond differently to weight loss in midlife than it does earlier in adulthood.

Researchers at Ben-Gurion University of the Negev examined young adult and mid-aged mice that became obese on a high-fat diet and were then switched back to standard chow to induce weight loss. In both age groups, the dietary switch rapidly normalized measures of blood-sugar control and glucose tolerance, indicating that key metabolic benefits of weight loss were seen regardless of age.

In mid-aged mice, however, the team found that early weight loss was accompanied by increased signs of inflammation in the hypothalamus, including changes in microglia—immune cells in the brain—detected through molecular analyses and microscopic imaging. The ScienceDaily summary of the work reported that this inflammatory response lasted several weeks before gradually declining.

The authors emphasize that the findings come from an animal model and do not establish that weight loss causes cognitive decline in people. Still, the researchers note that dysregulated or persistent neuroinflammation has been associated in other research with memory problems and neurodegenerative diseases, and they argue that the brain’s response to weight loss in midlife warrants closer study.

"Our findings show that losing weight in midlife is not a simple copy-and-paste of what works in young adulthood," said Alon Zemer, an M.D.-Ph.D. candidate and first author, in materials released by the university. "Weight loss remains essential for restoring metabolic health in obesity, but we need to understand the impact of weight loss on the mid-age brain and ensure brain health is not compromised."

Dr. Alexandra Tsitrina, also quoted in the release, said the study paired molecular profiling with structural imaging approaches to detect subtle changes during weight loss.

The study, titled "Weight loss aggravates obesity-induced hypothalamic inflammation in mid-aged mice," was published in the journal GeroScience. The university said the work was supported by an internal grant at Ben-Gurion University of the Negev, as well as grants from the U.S.-Israel Binational Science Foundation and the Israel Science Foundation.

Researchers said additional studies are needed to clarify why hypothalamic inflammatory changes appear to intensify during early weight loss in mid-aged mice and whether different weight-loss strategies could preserve metabolic benefits while limiting potential brain stress.

Relaterte artikler

Realistic illustration of obese mouse with FGF19 hormone pathway from gut to brain activating fat-burning brown adipose tissue for thermogenesis and obesity treatment research.
Bilde generert av AI

FGF19 hormone activates brain pathway to boost fat burning in obese mice

Rapportert av AI Bilde generert av AI Faktasjekket

A study in obese mice has found that the gut-derived hormone FGF19 can signal the brain to increase energy expenditure and activate fat-burning cells. Acting through the hypothalamus and the sympathetic nervous system, this mechanism enhances thermogenesis and cold tolerance and may help guide new treatments for obesity and diabetes.

New research published in Nature Medicine reveals that people with prediabetes can normalize blood sugar levels without losing weight. About one in four participants in lifestyle programs achieved this remission, offering protection against diabetes similar to weight loss methods. The key factors involve fat distribution and certain hormones.

Rapportert av AI

A new genomic analysis suggests that Alzheimer's disease may begin with inflammation in organs like the skin, lungs, or gut, potentially decades before brain symptoms appear. Researchers analyzed genetic data from hundreds of thousands of people and found risk genes more active outside the brain. This perspective could reshape prevention and treatment strategies.

University of Minnesota researchers report that older mice’s macrophages can become locked in an inflammatory state through an autocrine signaling loop involving the protein GDF3 and the transcription factors SMAD2/3. In experiments, genetic deletion of Gdf3 or drugs that interfered with the pathway reduced inflammatory responses and improved survival in older endotoxemia models, while human cohort data linked higher GDF3 levels with markers of inflammation.

Rapportert av AI Faktasjekket

Where fat is stored in the body—not only how much—is linked to brain structure and cognition, according to a large MRI study of nearly 26,000 UK Biobank participants. Researchers reported that two fat distribution profiles—one marked by high pancreatic fat and another often described as “skinny fat,” with high fat relative to muscle despite a less-obese appearance—were associated with gray-matter loss, faster brain aging and poorer cognitive outcomes.

A new imaging study suggests that higher muscle mass and a lower ratio of visceral fat to muscle are associated with a younger biological brain age. Presented at the Radiological Society of North America’s annual meeting, the research highlights how body composition may influence brain health and future risk of diseases such as Alzheimer’s.

Rapportert av AI

Researchers at The Rockefeller University have created a detailed cellular atlas of aging by analyzing nearly 7 million cells from 21 organs in mice. The study reveals that aging begins earlier than previously thought and occurs in a coordinated manner throughout the body. Findings highlight differences between males and females, along with potential targets for anti-aging therapies.

 

 

 

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis